Back to dashboard
Medicare AdvantagePrior AuthMedium impact

Update to Medical Benefit Drug Coverage for Medical Mutual Medicare Advantage Plans - December 2023

Medical Mutual of Ohio·Allergy & Immunology, Neurology, Hematology +2 more·Pharmacy
Effective date
Dec 1, 2023
We identified it
Jun 20, 2026
Days to comply

Summary

Medical Mutual Medicare Advantage plans now require trial of two preferred IVIG products before non-preferred IVIG can be prescribed for new patients. All IVIG medications require prior authorization with step therapy documentation.

Action Required

Action needed
Immediately: Update prior authorization workflows to document step therapy requirements for IVIG medications. Billing team must ensure providers submit documentation showing trial of two preferred IVIG products (Flebogamma, Gamunex-C, Gammagard Liquid, Gammagard S/D, Gammaked, Gammaplex, Octagam, or Privigen) before requesting non-preferred products. Follow Medical Mutual prior authorization process for all IVIG requests. Claims may be denied without proper step therapy documentation.

Affected Billing Codes

J1572
J1561
J1569
J1566
J1557
J1568
J1459
J1599
J1556
J1554